ADAR1 expression is positively regulated by JAK2 signaling, and is overexpressed in CML and presumably in other cancers where JAK2 signaling is increased [124]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.